https://prabadinews.com/
  • October 8, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

MET Inhibitor With Chemoimmunotherapy Overcomes Treatment Resistance in Some Patients With SCLC

MET Inhibitor With Chemoimmunotherapy Overcomes Treatment Resistance in Some Patients With SCLC

Both preclinical and translational evidence support MET inhibition as a therapeutic approach in patients with small cel lung cancer (SCLC).

administrator

Related Articles